<unk> , sold under the brand name Qelbree among others, is a medication which is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children and depression. It was marketed for more than two decades as an antidepressant in Europe before being repurposed as a treatment for ADHD and launched in the United States in April 2021.<unk>  is taken by mouth.<unk>  acts as a selective norepinephrine reuptake inhibitor (NRI). However, it may also act as an antagonist of the serotonin 5-HT2B receptor and as an agonist of the serotonin 5-HT2C receptors, actions which may be involved in its therapeutic effects.
Viloxazine
Indeloxazine
Hydrazoic acid
Cyamemazine
Ridinilazole
Indolocarbazole
Mestilbol
Clocortolone pivalate